Cough Mucus Relief Dm
NDC Package 70692-101-41

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Cough Mucus Relief Dm is * temporarily relieves cough due to minor throat and bronchial irritation associated with the common cold* helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive. Marketed by Strive Pharmaceuticals Inc., this product is identified by NDC 70692-101 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
70692-101-41
Package Description
4 TABLET in 1 PACKAGE
Product Code
70692-101
11-Digit Billing Format
70692010141
RxNorm Crosswalk
  • RxCUI: 1147685 - dextromethorphan HBr 20 MG / guaiFENesin 400 MG Oral Tablet
  • RxCUI: 1147685 - dextromethorphan hydrobromide 20 MG / guaifenesin 400 MG Oral Tablet
  • RxCUI: 1147685 - guaifenesin 400 MG / dextromethorphan HBr 20 MG Oral Tablet

Clinical Specifications

Proprietary Name
Cough Mucus Relief Dm
Dosage Form
-
Usage Information
* temporarily relieves cough due to minor throat and bronchial irritation associated with the common cold* helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive

Regulatory & Marketing

Labeler Name
Strive Pharmaceuticals Inc.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
02-15-2018
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70692-101). Click a package code to view its specific billing and regulatory data.

70692-101-24
24 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70692-101-41 identifies a specific commercial package of 4 tablet in 1 package of Cough Mucus Relief Dm, labeled by Strive Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Strive Pharmaceuticals Inc. on February 15, 2018. The current certification is valid through December 31, 2021.

How is this Strive Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70692010141. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70692-101-41
11-Digit CMS (5-4-2)
70692-0101-41

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.